Rapport Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$38.04

-1.89 (-4.73%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +18.8% upside

Low Target $32.24

Average Target $45.18

High Target $61.72

Current Price $38.04

Current
$38.04

Target
$45.18

$32.24 $45.18 avg $61.72

Scenario Analysis

Bear Case

$32.24

-15.2%

Low target

Base Case

$45.18

+18.8%

Avg target

Bull Case

$61.72

+62.3%

High target

Risk/Reward

4.1x

Highly favorable

Price in Context

52-Week High

$42.27

-10.0% from high

52-Week Low

$7.73

+392.1% from low

Target vs 52W High

$45.18

+6.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	36	44%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%